United States Biotechnology & Medical Research

Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences witnessed a single purchase of 971 shares by Rehan Verjee in September 2026, totaling approximately $20,000. This activity follows a period marked by multiple proposed divestments from major shareholders and officers. The stock has declined 35.2% over the last quarter, preceding the upcoming November earnings report.
Ticker: TYRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tyra Biosciences, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Verjee Rehan Non-Executive Director
Transaction date
Purchase
Price
146.31
Quantity 3,929 -30.0%
Value US$993,706
NEXTECH VI ONCOLOGY SCSP Shareholder
Transaction date
Proposed sale
Price
432.78
Quantity 18,854
Value US$2,270,775
NEXTECH VI ONCOLOGY SCSP Shareholder
Transaction date
Proposed sale
Price
319.74
Quantity 61,532
Value US$3,976,419
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
34.25
Quantity 8,000
Value US$274,000
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
35.63
Quantity 8,000
Value US$285,000
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
37.75
Quantity 53,172
Value US$2,007,153
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
36.97
Quantity 14,295 -33.6%
Value US$528,506
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
36.97
Quantity 14,295
Value US$528,506
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
35.38
Quantity 8,000
Value US$283,000
3.2
Bensen Daniel Chief Discovery Officer Officer
Transaction date
Planned sale
Price
33.37
Quantity 5,872 -3.8%
Value US$195,929
3.2
Bensen Daniel Chief Discovery Officer Officer
Transaction date
Planned sale
Price
31.50
Quantity 2,128 -1.4%
Value US$67,036
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
32.75
Quantity 8,000
Value US$262,000
3.2
Bensen Daniel Chief Discovery Officer Officer
Transaction date
Planned sale
Price
29.08
Quantity 1,017 -0.7%
Value US$29,575
3.2
Bensen Daniel Chief Discovery Officer Officer
Transaction date
Planned sale
Price
28.44
Quantity 6,983 -4.3%
Value US$198,610
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
29.00
Quantity 8,000
Value US$232,000
2.8
MORE ROBERT J Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 10,000 -0.3%
Value US$250,000
3.2
Bensen Daniel Chief Discovery Officer Officer
Transaction date
Planned sale
Price
22.64
Quantity 8,000 -4.7%
Value US$181,159
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
22.50
Quantity 8,000
Value US$180,000
2.8
MORE ROBERT J Non-Executive Director
Transaction date
Planned sale
Price
20.25
Quantity 246,871 -6.1%
Value US$5,000,026
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
16.32
Quantity 49,956 -22.6%
Value US$815,297
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
16.07
Quantity 75,633 -25.5%
Value US$1,215,627
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
16.05
Quantity 124,589
Value US$2,000,000
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
15.94
Quantity 20,072
Value US$320,000
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
17.07
Quantity 1,500 -0.5%
Value US$25,607
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
16.11
Quantity 18,572 -5.9%
Value US$299,191
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
16.02
Quantity 110,228 -25.8%
Value US$1,765,489
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
15.98
Quantity 86,339
Value US$1,380,000
3.2
Bensen Daniel Chief Operating Officer Officer
Transaction date
Planned sale
Price
16.00
Quantity 1,111 -0.3%
Value US$17,780
3.2
Daniel Bensen Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 25,000
Value US$400,000
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
9.78
Quantity 9,568 -25.3%
Value US$93,596
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
9.78
Quantity 9,568
Value US$93,596
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
10.35
Quantity 10 -0.0%
Value US$104
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
10.35
Quantity 10
Value US$104
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
10.38
Quantity 6,814
Value US$70,726
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.13
Quantity 11,813 +0.1%
Value US$119,666
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
10.38
Quantity 6,814 -15.3%
Value US$70,726
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.20
Quantity 120,167 +1.2%
Value US$1,225,703
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
10.31
Quantity 15,000 -25.2%
Value US$154,582
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
10.31
Quantity 15,000
Value US$154,582
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.20
Quantity 31,307 +0.3%
Value US$319,331
2.0
KAPLAN GILLA Non-Executive Director
Transaction date
Sale
Price
10.31
Quantity 30,000 -33.5%
Value US$309,255
2.0
GILLA KAPLAN Director Non-Executive Director
Transaction date
Proposed sale
Price
10.31
Quantity 30,000
Value US$309,255
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.19
Quantity 186,850 +1.9%
Value US$1,904,002
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.04
Quantity 213,334 +2.2%
Value US$2,141,873
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
9.63
Quantity 997,864 +11.5%
Value US$9,609,430
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
13.76
Quantity 3,511 -0.8%
Value US$48,315
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
13.76
Quantity 1,890 -0.1%
Value US$26,008
2.0
Canaan XI, LP Director Non-Executive Director
Transaction date
Proposed sale
Price
13.75
Quantity 120,000
Value US$1,650,000
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.26
Quantity 4,825 -0.1%
Value US$78,466
Subramony Siddarth Director Non-Executive Director
Transaction date
Proposed sale
Price
15.71
Quantity 18,597
Value US$292,236
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.36
Quantity 3,993 -0.1%
Value US$65,336
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.40
Quantity 461 -0.1%
Value US$7,560
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.40
Quantity 12,808 -0.3%
Value US$210,052
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.29
Quantity 835 -0.2%
Value US$13,600
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.29
Quantity 6,944 -0.2%
Value US$113,097
Tada Hiroomi Officer Officer
Transaction date
Proposed sale
Price
15.90
Quantity 10,000
Value US$159,000
Tada Hiroomi Officer Officer
Transaction date
Proposed sale
Price
15.00
Quantity 5,000
Value US$75,000
Tada Hiroomi Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 5,000
Value US$80,000
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.84
Quantity 566 -0.1%
Value US$9,531
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.84
Quantity 4,706 -0.1%
Value US$79,242
Tada Hiroomi Officer Officer
Transaction date
Proposed sale
Price
15.47
Quantity 10,000
Value US$154,700
Tada Hiroomi Officer Officer
Transaction date
Proposed sale
Price
15.94
Quantity 10,107
Value US$161,106
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.25
Quantity 1,220,681 +16.3%
Value US$19,836,066
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.32
Quantity 2,371 -0.5%
Value US$41,061
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.32
Quantity 19,720 -0.5%
Value US$341,513
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.18
Quantity 5,635 -1.2%
Value US$96,784
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.18
Quantity 46,856 -1.2%
Value US$804,775
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.77
Quantity 1,126 -0.2%
Value US$18,881
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.77
Quantity 9,367 -0.2%
Value US$157,069
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.01
Quantity 116 -0.0%
Value US$1,973
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.01
Quantity 960 -0.0%
Value US$16,326
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
17.16
Quantity 73 -0.0%
Value US$1,253
4.0
Kjellson Nina S Non-Executive Director
Transaction date
Sale
Price
16.54
Quantity 2,878 -0.6%
Value US$47,615
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-11 2026-09-09 B Purchase
Verjee Rehan
Non-Executive Director
3,929 -30.0%
146.31
US$993,706 		3,929 -30.0% 146.31 US$993,706
2026-06-26 2026-06-26 PrS Proposed sale
NEXTECH VI ONCOLOGY SCSP

Shareholder
18,854
432.78
US$2,270,775 		18,854 432.78 US$2,270,775
2026-06-01 2026-06-01 PrS Proposed sale
NEXTECH VI ONCOLOGY SCSP

Shareholder
61,532
319.74
US$3,976,419 		61,532 319.74 US$3,976,419
2026-05-12 2026-05-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
34.25
US$274,000 		8,000 34.25 US$274,000
2026-04-13 2026-04-13 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
35.63
US$285,000 		8,000 35.63 US$285,000
2026-03-26 2026-03-26 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
53,172
37.75
US$2,007,153 		53,172 37.75 US$2,007,153
2026-03-27 2026-03-25 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
14,295 -33.6%
36.97
US$528,506 		14,295 -33.6% 36.97 US$528,506
2026-03-25 2026-03-25 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
14,295
36.97
US$528,506 		14,295 36.97 US$528,506
2026-03-12 2026-03-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
35.38
US$283,000 		8,000 35.38 US$283,000
2026-02-13 2026-02-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
5,872 -3.8%
33.37
US$195,929 		5,872 -3.8% 33.37 US$195,929
2026-02-13 2026-02-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
2,128 -1.4%
31.50
US$67,036 		2,128 -1.4% 31.50 US$67,036
2026-02-12 2026-02-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
32.75
US$262,000 		8,000 32.75 US$262,000
2026-01-20 2026-01-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
1,017 -0.7%
29.08
US$29,575 		1,017 -0.7% 29.08 US$29,575
2026-01-20 2026-01-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
6,983 -4.3%
28.44
US$198,610 		6,983 -4.3% 28.44 US$198,610
2026-01-12 2026-01-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
29.00
US$232,000 		8,000 29.00 US$232,000
2025-12-19 2025-12-19 PlS Planned sale
2.8
MORE ROBERT J
Non-Executive Director
10,000 -0.3%
25.00
US$250,000 		10,000 -0.3% 25.00 US$250,000
2025-12-16 2025-12-12 PlS Planned sale
3.2
Bensen Daniel

Chief Discovery Officer

Officer
8,000 -4.7%
22.64
US$181,159 		8,000 -4.7% 22.64 US$181,159
2025-12-12 2025-12-12 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
8,000
22.50
US$180,000 		8,000 22.50 US$180,000
2025-11-25 2025-11-21 PlS Planned sale
2.8
MORE ROBERT J
Non-Executive Director
246,871 -6.1%
20.25
US$5,000,026 		246,871 -6.1% 20.25 US$5,000,026
2025-11-21 2025-11-21 PrS Proposed sale
Alta Partners NextGen Fund II, L.P.

Affiliate
256,871
21.00
US$5,394,291 		256,871 21.00 US$5,394,291
2025-11-19 2025-11-19 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
49,956 -22.6%
16.32
US$815,297 		49,956 -22.6% 16.32 US$815,297
2025-11-19 2025-11-18 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
75,633 -25.5%
16.07
US$1,215,627 		75,633 -25.5% 16.07 US$1,215,627
2025-11-18 2025-11-18 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
124,589
16.05
US$2,000,000 		124,589 16.05 US$2,000,000
2025-11-17 2025-11-17 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
20,072
15.94
US$320,000 		20,072 15.94 US$320,000
2025-11-17 2025-11-17 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
1,500 -0.5%
17.07
US$25,607 		1,500 -0.5% 17.07 US$25,607
2025-11-17 2025-11-17 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
18,572 -5.9%
16.11
US$299,191 		18,572 -5.9% 16.11 US$299,191
2025-11-17 2025-11-14 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
110,228 -25.8%
16.02
US$1,765,489 		110,228 -25.8% 16.02 US$1,765,489
2025-11-14 2025-11-14 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
86,339
15.98
US$1,380,000 		86,339 15.98 US$1,380,000
2025-11-17 2025-11-13 PlS Planned sale
3.2
Bensen Daniel

Chief Operating Officer

Officer
1,111 -0.3%
16.00
US$17,780 		1,111 -0.3% 16.00 US$17,780
2025-11-13 2025-11-13 PrS Proposed sale
3.2
Daniel Bensen

Officer

Officer
25,000
16.00
US$400,000 		25,000 16.00 US$400,000
2025-06-20 2025-06-18 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
9,568 -25.3%
9.78
US$93,596 		9,568 -25.3% 9.78 US$93,596
2025-06-18 2025-06-18 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
9,568
9.78
US$93,596 		9,568 9.78 US$93,596
2025-06-20 2025-06-17 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
10 -0.0%
10.35
US$104 		10 -0.0% 10.35 US$104
2025-06-17 2025-06-17 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
10
10.35
US$104 		10 10.35 US$104
2025-06-16 2025-06-16 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
6,814
10.38
US$70,726 		6,814 10.38 US$70,726
2025-06-16 2025-06-16 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
11,813 +0.1%
10.13
US$119,666 		11,813 +0.1% 10.13 US$119,666
2025-06-16 2025-06-16 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
6,814 -15.3%
10.38
US$70,726 		6,814 -15.3% 10.38 US$70,726
2025-06-16 2025-06-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
120,167 +1.2%
10.20
US$1,225,703 		120,167 +1.2% 10.20 US$1,225,703
2025-06-16 2025-06-13 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
15,000 -25.2%
10.31
US$154,582 		15,000 -25.2% 10.31 US$154,582
2025-06-13 2025-06-13 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
15,000
10.31
US$154,582 		15,000 10.31 US$154,582
2025-06-16 2025-06-12 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
31,307 +0.3%
10.20
US$319,331 		31,307 +0.3% 10.20 US$319,331
2025-06-16 2025-06-12 S Sale
2.0
KAPLAN GILLA
Non-Executive Director
30,000 -33.5%
10.31
US$309,255 		30,000 -33.5% 10.31 US$309,255
2025-06-12 2025-06-12 PrS Proposed sale
2.0
GILLA KAPLAN

Director

Non-Executive Director
30,000
10.31
US$309,255 		30,000 10.31 US$309,255
2025-06-11 2025-06-09 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
186,850 +1.9%
10.19
US$1,904,002 		186,850 +1.9% 10.19 US$1,904,002
2025-06-06 2025-06-05 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
213,334 +2.2%
10.04
US$2,141,873 		213,334 +2.2% 10.04 US$2,141,873
2025-06-06 2025-06-04 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
997,864 +11.5%
9.63
US$9,609,430 		997,864 +11.5% 9.63 US$9,609,430
2025-02-07 2025-02-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
3,511 -0.8%
13.76
US$48,315 		3,511 -0.8% 13.76 US$48,315
2025-02-07 2025-02-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
1,890 -0.1%
13.76
US$26,008 		1,890 -0.1% 13.76 US$26,008
2025-02-05 2025-02-05 PrS Proposed sale
2.0
Canaan XI, LP

Director

Non-Executive Director
120,000
13.75
US$1,650,000 		120,000 13.75 US$1,650,000
2025-02-05 2025-02-05 PrS Proposed sale
Canaan 2020 Plus Co-Investment LP - Series 7

Director

Non-Executive Director
112,500
13.75
US$1,546,875 		112,500 13.75 US$1,546,875
2025-01-27 2025-01-23 S Sale
4.0
Kjellson Nina S
Non-Executive Director
4,825 -0.1%
16.26
US$78,466 		4,825 -0.1% 16.26 US$78,466
2025-01-22 2025-01-22 PrS Proposed sale
Subramony Siddarth

Director

Non-Executive Director
18,597
15.71
US$292,236 		18,597 15.71 US$292,236
2025-01-21 2025-01-21 S Sale
4.0
Kjellson Nina S
Non-Executive Director
3,993 -0.1%
16.36
US$65,336 		3,993 -0.1% 16.36 US$65,336
2025-01-21 2025-01-17 S Sale
4.0
Kjellson Nina S
Non-Executive Director
461 -0.1%
16.40
US$7,560 		461 -0.1% 16.40 US$7,560
2025-01-21 2025-01-17 S Sale
4.0
Kjellson Nina S
Non-Executive Director
12,808 -0.3%
16.40
US$210,052 		12,808 -0.3% 16.40 US$210,052
2025-01-21 2025-01-16 S Sale
4.0
Kjellson Nina S
Non-Executive Director
835 -0.2%
16.29
US$13,600 		835 -0.2% 16.29 US$13,600
2025-01-21 2025-01-16 S Sale
4.0
Kjellson Nina S
Non-Executive Director
6,944 -0.2%
16.29
US$113,097 		6,944 -0.2% 16.29 US$113,097
2024-12-09 2024-12-09 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,000
15.90
US$159,000 		10,000 15.90 US$159,000
2024-12-05 2024-12-05 PrS Proposed sale
Tada Hiroomi

Officer

Officer
5,000
15.00
US$75,000 		5,000 15.00 US$75,000
2024-12-02 2024-12-02 PrS Proposed sale
Tada Hiroomi

Officer

Officer
5,000
16.00
US$80,000 		5,000 16.00 US$80,000
2024-11-26 2024-11-25 S Sale
4.0
Kjellson Nina S
Non-Executive Director
566 -0.1%
16.84
US$9,531 		566 -0.1% 16.84 US$9,531
2024-11-26 2024-11-25 S Sale
4.0
Kjellson Nina S
Non-Executive Director
4,706 -0.1%
16.84
US$79,242 		4,706 -0.1% 16.84 US$79,242
2024-11-20 2024-11-20 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,000
15.47
US$154,700 		10,000 15.47 US$154,700
2024-11-14 2024-11-14 PrS Proposed sale
Tada Hiroomi

Officer

Officer
10,107
15.94
US$161,106 		10,107 15.94 US$161,106
2024-11-13 2024-11-08 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,220,681 +16.3%
16.25
US$19,836,066 		1,220,681 +16.3% 16.25 US$19,836,066
2024-11-08 2024-11-07 S Sale
4.0
Kjellson Nina S
Non-Executive Director
2,371 -0.5%
17.32
US$41,061 		2,371 -0.5% 17.32 US$41,061
2024-11-08 2024-11-07 S Sale
4.0
Kjellson Nina S
Non-Executive Director
19,720 -0.5%
17.32
US$341,513 		19,720 -0.5% 17.32 US$341,513
2024-11-08 2024-11-06 S Sale
4.0
Kjellson Nina S
Non-Executive Director
5,635 -1.2%
17.18
US$96,784 		5,635 -1.2% 17.18 US$96,784
2024-11-08 2024-11-06 S Sale
4.0
Kjellson Nina S
Non-Executive Director
46,856 -1.2%
17.18
US$804,775 		46,856 -1.2% 17.18 US$804,775
2024-11-06 2024-11-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
1,126 -0.2%
16.77
US$18,881 		1,126 -0.2% 16.77 US$18,881
2024-11-06 2024-11-05 S Sale
4.0
Kjellson Nina S
Non-Executive Director
9,367 -0.2%
16.77
US$157,069 		9,367 -0.2% 16.77 US$157,069
2024-11-06 2024-11-04 S Sale
4.0
Kjellson Nina S
Non-Executive Director
116 -0.0%
17.01
US$1,973 		116 -0.0% 17.01 US$1,973
2024-11-06 2024-11-04 S Sale
4.0
Kjellson Nina S
Non-Executive Director
960 -0.0%
17.01
US$16,326 		960 -0.0% 17.01 US$16,326
2024-11-01 2024-11-01 S Sale
4.0
Kjellson Nina S
Non-Executive Director
73 -0.0%
17.16
US$1,253 		73 -0.0% 17.16 US$1,253
2024-11-01 2024-11-01 S Sale
4.0
Kjellson Nina S
Non-Executive Director
2,878 -0.6%
16.54
US$47,615 		2,878 -0.6% 16.54 US$47,615

See older Tyra Biosciences, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Tyra Biosciences, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Tyra Biosciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America